Careers  |  Sign In  |  Register  |   Twitter

Latest in Cardiology

The U.S. government has cleared AstraZeneca’s heart drug Brilinta after a controversial clinical trial in eastern Europe, a Reuters article reports. Last October, the Department of Justice launched an investigation into discrepancies between the company’s reported effectiveness and the results by an...
While it is generally accepted that high sodium intake comes with many cardiovascular risks, two new studies suggest that extremely low-sodium diets come with their own dangers, according to an article published by Reuters. Published in the New England Journal of Medicine, the first study focused on death...
A large new study has linked post-surgery atrial fibrillation to a significant increase in risk of future stroke. According to an article published in the New York Times’ Well Blog, the study, published in the Journal of the American Medical Association, followed 1.7 million patients who did not have a...